ACTU says 1.5 million workers are exposed to cancer-causing chemicals

NewsGuard 100/100 Score

According to the Australian Council of Trade Unions (ACTU), exposure to cancer-causing substances at work threatens the health and well being of as many as 1.5 million Australians.

The ACTU says construction workers are among those most affected by working with varying levels of cancer-causing substances.

International research shows people who work in the transport and defence industries as well as construction are most at risk because they can come into contact with toxic substances such as asbestos.

ACTU spokesman Geoff Fary says the risk is greater for men than women, with 12 per cent of all male workers exposed to carcinogens and with this in mind the ACTU is launching an information campaign to raise awareness among workers, governments and employers of the presence of dangerous substances in the workplace.

The ACTU says it is unacceptable in this day and age that people at work are exposed to substances which injure their health or have the potential to kill them.

ACTU president Sharan Burrow says Australia has the highest rate of recorded mesothelioma in the world, with exposure to asbestos the only known cause of the disease and she has called on the federal government to launch a national inquiry into asbestos in Australia.

The ACTU wants a national inquiry into asbestos in order to examine ways to eliminate it from workplaces and homes in Australia and to also examine possible compensation and treatment for those affected.

The ACTU estimates around 6,700 Australians die every year from workplace injuries or disease and the call for an asbestos inquiry coincides with International Workers Memorial Day, which commemorates the two million workers around the world who have died in the past 12 months.

The ACTU says around 6,700 Australians die every year from workplace injuries or disease.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels